NCTId,BriefTitle,OverallStatus,StudyType,Phases,Conditions,LeadSponsorName,StartDate,StudyFirstPostDate,LastUpdatePostDate,Timestamp
NCT00873782,Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE1,"Muscular Dystrophies, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb-Girdle Muscular Dystrophy","University of North Carolina, Chapel Hill",2009-03,2009-04-02,2015-03-09,2024-11-15T07:19:24.926538
NCT04687020,Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE4,Duchenne Muscular Dystrophy,"NS Pharma, Inc.",2021-06-10,2020-12-29,2022-10-19,2024-11-15T07:19:24.926538
NCT02369731,Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD),ACTIVE_NOT_RECRUITING,OBSERVATIONAL,,"Muscular Dystrophy, Duchenne",PTC Therapeutics,2015-04-30,2015-02-24,2024-10-09,2024-11-15T07:19:24.926538
